<DOC>
	<DOC>NCT00931541</DOC>
	<brief_summary>The aims of the study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD6088 following single ascending dose administration in healthy male and non-fertile females.</brief_summary>
	<brief_title>AZD6088 Single Ascending Dose Study</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Caucasian male and nonfertile female healthy volunteers aged ≥18 to ≤55 years with suitable veins for cannulation or repeated venipuncture. Clinically normal physical findings including supine BP, pulse rate, ECG and laboratory assessments in relation to age, as judged by the investigator. Normal and suitable EEG, as judged by a neurologist History of any clinically significant disease or disorder which for instance includes CNS disorder or CV disorder. Any clinically significant abnormalities in clinical chemistry, haematology or urinalysis results as judged by the investigator. Any clinically important abnormalities in the ECG.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Healthy</keyword>
</DOC>